Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Fri, 07/31/2020 - 07:15	Opened		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter opened	Fri, 07/31/2020 - 06:11	Opened		Anonym
Newsletter clicked	Fri, 07/31/2020 - 05:53	Clicked https://japan.progress.im/ja/content/%E6%97%A5%E6%9C%AC%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E7%B2%BE%E7%A5%9E%E7%96%BE%E6%82%A3%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8B%E3%82%B9%E3%83%86%E3%82%A3%E3%82%B0%E3%83%9E%E3%81%8A%E3%82%88%E3%81%B3%E3%81%9D%E3%81		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter opened	Fri, 07/31/2020 - 02:44	Opened		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Anonym

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Fri, 07/31/2020 - 07:15	Opened		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter opened	Fri, 07/31/2020 - 06:11	Opened		Anonym
Newsletter clicked	Fri, 07/31/2020 - 05:53	Clicked https://japan.progress.im/ja/content/%E6%97%A5%E6%9C%AC%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E7%B2%BE%E7%A5%9E%E7%96%BE%E6%82%A3%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8B%E3%82%B9%E3%83%86%E3%82%A3%E3%82%B0%E3%83%9E%E3%81%8A%E3%82%88%E3%81%B3%E3%81%9D%E3%81		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter opened	Fri, 07/31/2020 - 02:44	Opened		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Anonym

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER